Filter by category, search by name. Each profile is graded on a five-tier evidence scale.
ACTH(4-7)PGP
Russian-developed neuropeptide approved in Russia for stroke and TBI. Increases BDNF and NGF. Intranasal administration crosses blood-brain barrier effectively. Under FDA review for US Category 1 status.
PNB-0408 / N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
Estimated 7 million times more potent than BDNF at forming new synaptic connections in animal models. Developed at Washington State University for dementia research. Significant cancer concern via MET oncogene.
Vasoactive Intestinal Peptide
28-amino acid neuropeptide with remarkable anti-inflammatory lung-protective and cognitive properties. Significant research interest for Long COVID and chronic inflammatory response syndrome.
